THE VALUE OF FDG-PET/CT IN ASSESSMENT OF PATIENTS WITH NON-HODGKIN'S LYMPHOMA OF TONSIL

被引：0
|
作者：
Tamam, M. Oner [1 ]
机构：
[1] Univ Hlth Sci, Okmeydani Training & Res Hosp, Istanbul, Turkey
来源：
LEUKEMIA RESEARCH | 2017年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP-18
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [31] The Role of FDG PET/CT Detecting Bone Marrow Involvement in Non-Hodgkin's Lymphoma Patients
    Kupik, O.
    Akin, S.
    Tuncel, M.
    Turker, A.
    Kars, A.
    Erbas, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S490 - S490
  • [32] Evaluation of bone marrow involvement (BMI) by FDG-PET/CT in patients with newly diagnosed high grade non-Hodgkin's lymphoma
    Lee, Yukyung
    Hong, Junshik
    Hwang, Kyung Hoon
    Kim, Seog Gyun
    Lee, Haejun
    Kim, Jihyun
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [33] NERVOUS SYSTEM INVOLVEMENT BY RECURRENCE OF NON-HODGKIN LYMPHOMA ON FDG-PET/CT: LEPTOMENINGEAL DISEASE AND NEUROLYMPHOMATOSIS
    Iravani, A.
    Bui, C.
    Shen, L.
    Mansberg, R.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 22 - 23
  • [34] Prognostic value of interim PET/CT in non-hodgkin lymphoma
    Ladron de Guevara, David
    Bernard, Sebastian
    Manhood, Susana
    Melani, Sophia
    Yerovi, Fernando
    de los Angeles Rodriguez, Maria
    REVISTA MEDICA DE CHILE, 2020, 148 (11) : 1558 - 1567
  • [35] The role of FDG PET/CT in the management of extranodal non-Hodgkin lymphoma
    Bural, Gonca
    Oborski, Matthew
    Mountz, James
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54
  • [36] Role of FDG-PET/CT study in the detection of "patchy" bone marrow disease in patients with aggressive Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL).
    Pelosi, E. E.
    Deandreis, D.
    Penna, D.
    Chiappella, A.
    Pregno, P.
    Racca, M.
    Carra, F.
    Douroukas, A.
    Vitolo, U.
    Bisi, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S256 - S256
  • [37] Evaluation of FDG-PET for initial staging and therapy monitoring in pediatric patients with Non-Hodgkin lymphoma
    Furth, C.
    Ruf, J.
    Denecke, T.
    Hundsdoerfer, P.
    Voelker, T.
    Seeger, K.
    Gutberlet, M.
    Stoever, B.
    Felix, R.
    Henze, G.
    Amthauer, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S75 - S75
  • [38] FDG-PET is a valid predictor for relapse free survival in non-Hodgkin's lymphoma.
    de Wit, M
    Tuinmann, G
    Bohuslavizki, KH
    Buchert, R
    Clausen, M
    Hossfeld, DK
    ANNALS OF ONCOLOGY, 2000, 11 : 100 - 100
  • [39] Can FDG-PET predict outcome after radioimmunotherapy in recurrent non-Hodgkin's lymphoma?
    Scheidhauer, K
    Wolf, I
    Rose, C
    von Schilling, C
    Schmidt, B
    Schwarz, K
    Reidel, G
    Peschel, C
    Schwaiger, M
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 78P - 78P
  • [40] Unilateral testicular relapse of abdominal non-Hodgkin lymphoma detected by FDG-PET
    Basu, S
    Nair, N
    PEDIATRIC RADIOLOGY, 2006, 36 (03) : 274 - 275
12345